logo
Select company
Select metric
18.63%Cash to Assets Ratio
VS
Market
73
Sector
43
Industry
30
History
-
$ 45.78Close
$ 10.8 - $ 80.04 52-Week Range
Ticker Information

Ticker

KRRO

Company Name

KORRO BIO INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

KORRO BIO INC - Cash to Assets Ratio Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

KRRO - Cash to Assets Historical data
DateTotal AssetsCash and EquivalentsCash to Assets Ratio
6/30/2025$ 180.43M$ 33.61M18.63%
3/31/2025$ 202.21M$ 64.14M31.72%
12/31/2024$ 226.24M$ 55.64M24.59%
9/30/2024$ 243.54M$ 64.97M26.68%
6/30/2024$ 249.59M$ 92.92M37.23%
3/31/2024$ 197.99M$ 142.35M71.9%
12/31/2023$ 221.66M$ 169.71M76.56%
9/30/2023$ 46.35M$ 43.69M94.26%
6/30/2023$ 79.38M$ 41.67M52.49%
3/31/2023$ 101.5M$ 42.55M41.92%
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • KORRO BIO INC's latest trailing twelve months (TTM) Cash to Assets stands at 96.47%.
  • Over the past 5 years, KORRO BIO INC's average Cash to Assets has been 51.4%.
  • The median Cash to Assets for KORRO BIO INC during this period was 44.07%
  • KORRO BIO INC reached its highest Cash to Assets over the past 5 years at 96.47%.
  • The lowest Cash to Assets recorded by KORRO BIO INC in the same timeframe 18.63%

KORRO BIO INC's Cash to Assets vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

Cash to Assets Benchmarks
CompanyCash to Assets
CRBU : CARIBOU BIOSCIENCES INC 11.41%ACOG : ALPHA COGNITION INC 87.46%TCRX : TSCAN THERAPEUTICS INC 58.42%TVRD : TVARDI THERAPEUTICS INC 47.2%OBIO : ORCHESTRA BIOMED HOLDINGS INC 43.78%FATE : FATE THERAPEUTICS INC 13.85%CRVO : CERVOMED INC 21.85%OVID : OVID THERAPEUTICS INC 39.19%CBUS : CIBUS INC 10.53%ARMP : ARMATA PHARMACEUTICALS INC 12.03%

Definition of Cash to Assets Ratio

[Calculation] The Cash to Assets Ratio expresses a company’s cash and cash equivalents [CashnEq] as a percentage of total [Assets].
CashnEq / Assets
(=) Cash to Assets
Cash to Assets for KORRO BIO INC is calculated as follows: CashnEq [ $ 226.05M ] / Assets [ $ 234.32M ]
(=) Cash to Assets [ 96.47% ]

KRRO - Cash to Assets Ratio, Last 5 years

18.63%

Minimum

Jun 30, 2025

96.47%

Maximum

Sep 30, 2020

51.4%

Average

44.07%

Median

Cash to Assets Benchmark Analysis

The chart above depicts the distribution of Cash to Assets for companies in the Total Stock Market. The average Cash to Assets of the companies is 9.78% with a standard deviation of 9.53%.
The following table provides additional summary stats:
Cash to Assets in the Market:
filtered constituents3.94K
min0%
max40.76%
average9.78%
median6.42%
std9.53%